Viridian Therapeutics, Inc.
VRDN
$16.86
-$0.34-1.98%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 19.72% | 21.89% | -34.83% | -1.40% | 3.82% |
| Total Receivables | -- | -- | 499,900.00% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 9.50% | -6.21% | -21.92% | 49.49% | 52.30% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 19.40% | 21.09% | -25.47% | -0.50% | 4.85% |
|
|
|||||
| Total Current Assets | 19.40% | 21.09% | -25.47% | -0.50% | 4.85% |
| Net Property, Plant & Equipment | 4.03% | 6.04% | 0.46% | -8.14% | 8.18% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 81.60% | 206.59% | 77.96% | -23.22% | -11.89% |
| Total Assets | 19.37% | 21.15% | -25.23% | -0.57% | 4.85% |
|
|
|||||
| Total Accounts Payable | 242.59% | 305.18% | 58.77% | 171.27% | 45.22% |
| Total Accrued Expenses | 29.61% | 35.53% | 16.10% | 16.89% | 29.49% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 37.69% | 46.78% | 23.94% | 158.95% | -26.78% |
| Total Finance Division Other Current Liabilities | -29.38% | 27.43% | -4.12% | -25.77% | 0.00% |
| Total Other Current Liabilities | -29.38% | 27.43% | -4.12% | -25.77% | 0.00% |
| Total Current Liabilities | 53.60% | 47.67% | 22.56% | 43.04% | 29.09% |
|
|
|||||
| Total Current Liabilities | 53.60% | 47.67% | 22.56% | 43.04% | 29.09% |
| Long-Term Debt | 143.83% | 142.64% | 1.79% | -29.36% | 1.76% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 15.50% | -- | 19.48% | 5.65% | 110.27% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 22,820.75% | 2,270.67% | -- | 11.19% | -57.60% |
| Total Liabilities | 170.77% | 150.48% | 15.16% | 19.23% | 18.09% |
|
|
|||||
| Common Stock & APIC | 30.02% | 30.40% | 6.84% | 29.08% | 29.41% |
| Retained Earnings | -33.30% | -34.40% | -32.96% | -40.99% | -39.81% |
| Treasury Stock & Other | -327.76% | 4,570.00% | -61.05% | 112.71% | 166.76% |
| Total Common Equity | 21.26% | 22.24% | -39.44% | -1.01% | 8.56% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -30.09% | -30.09% | 0.00% | -5.42% | -5.42% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -30.09% | -30.09% | 0.00% | -5.42% | -5.42% |
|
|
|||||
| Total Common Equity | 21.26% | 22.24% | -39.44% | -1.01% | 8.56% |
| Total Preferred Equity | -30.09% | -30.09% | 0.00% | -5.42% | -5.42% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.22% | 7.52% | -28.91% | -2.68% | 3.77% |
|
|
|||||